23 Feb
2021

How hub-and-spoke businesses are creating new pharma IP monetisation models

The newly-launched Centessa is the latest in a series of decentralised, asset-centred businesses disrupting patterns of pharma IP deal-making

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth